In contrast, selective stimulation of 5‐HT1A receptors in the mPFC exerts rapid and sustained antidepressant‐like effects via activation of AMPAR/BDNF/mTOR signaling in mice, which provides evidence for the targeting of 5‐HT1A receptor in the treatment of MDD.362. The gene discussed is HTR1A; the disease is major depressive disorder.